These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21622196)

  • 1. Role of purinergic receptor polymorphisms in human bone.
    Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity P2Y2 and low-affinity P2X7 receptor interaction modulates ATP-mediated calcium signaling in murine osteoblasts.
    Mikolajewicz N; Smith D; Komarova SV; Khadra A
    PLoS Comput Biol; 2021 Jun; 17(6):e1008872. PubMed ID: 34153025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation.
    Gartland A; Buckley KA; Hipskind RA; Bowler WB; Gallagher JA
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):237-42. PubMed ID: 14696970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP P2 receptors and regulation of bone effector cells.
    Gallagher JA
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):125-7. PubMed ID: 15615109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a P2X7 receptor by a subpopulation of human osteoblasts.
    Gartland A; Hipskind RA; Gallagher JA; Bowler WB
    J Bone Miner Res; 2001 May; 16(5):846-56. PubMed ID: 11341329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
    Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
    J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of P2 receptors in bone and cultured bone cells.
    Hoebertz A; Townsend-Nicholson A; Glass R; Burnstock G; Arnett TR
    Bone; 2000 Oct; 27(4):503-10. PubMed ID: 11033445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the P2Y
    Orriss IR; Guneri D; Hajjawi MOR; Shaw K; Patel JJ; Arnett TR
    J Endocrinol; 2017 Jun; 233(3):341-356. PubMed ID: 28420708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purinergic P2X7 ion channel receptor-a 'repair' receptor in bone.
    Jørgensen NR
    Curr Opin Immunol; 2018 Jun; 52():32-38. PubMed ID: 29587220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
    Korcok J; Raimundo LN; Du X; Sims SM; Dixon SJ
    J Biol Chem; 2005 Apr; 280(17):16909-15. PubMed ID: 15722352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [P2 purinergic receptors: regulation of bone metabolism and therapeutic potential?].
    Solgaard M; Jørgensen NR
    Ugeskr Laeger; 2005 Aug; 167(34):3152-6. PubMed ID: 16117911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption.
    Bowler WB; Littlewood-Evans A; Bilbe G; Gallagher JA; Dixon CJ
    Bone; 1998 Mar; 22(3):195-200. PubMed ID: 9514211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone phenotypes of P2 receptor knockout mice.
    Orriss I; Syberg S; Wang N; Robaye B; Gartland A; Jorgensen N; Arnett T; Boeynaems JM
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1038-46. PubMed ID: 21622253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.
    Wang N; Robaye B; Agrawal A; Skerry TM; Boeynaems JM; Gartland A
    Mol Endocrinol; 2012 Jan; 26(1):142-52. PubMed ID: 22108801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signalling in osteoblasts.
    Gartland A; Orriss IR; Rumney RM; Bond AP; Arnett T; Gallagher JA
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):16-29. PubMed ID: 22201729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling.
    Bowler WB; Buckley KA; Gartland A; Hipskind RA; Bilbe G; Gallagher JA
    Bone; 2001 May; 28(5):507-12. PubMed ID: 11344050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.
    Woo SH; Trinh TN
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of osteoblast function and bone mineralisation by extracellular nucleotides: The role of p2x receptors.
    Orriss IR; Key ML; Brandao-Burch A; Patel JJ; Burnstock G; Arnett TR
    Bone; 2012 Sep; 51(3):389-400. PubMed ID: 22749889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signalling and bone remodelling.
    Orriss IR; Burnstock G; Arnett TR
    Curr Opin Pharmacol; 2010 Jun; 10(3):322-30. PubMed ID: 20189453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.